Search

Search Constraints

You searched for: Author/Creator Vidimar, Vania

Search Results

1. A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53. (January 2019)

2. Anticancer activity of ruthenium and osmium cyclometalated compounds: identification of ABCB1 and EGFR as resistance mechanisms. Issue 3 (9th December 2019)